South Korea Reports Quadruple Breast Cancer Cases Over Past 15 Years
This article was originally published in PharmAsia News
South Korea statistics indicate the number of breast cancer cases quadrupled over the past 15 years, with experts attributing the increase to Western lifestyles as well as lower birth rates and breastfeeding.
You may also be interested in...
US regulators refused to accept the file for one of Y-mAbs's neuroblasoma drugs – omburtamab – in October but have given the green light to a second one, naxitamab.
Fueled by a pipeline of more than 15 biosimilar candidates, Sandoz is aiming to treble the size of its $2bn global biosimilars business by 2030, targeting the US, Europe and Japan. Management spoke at length about the firm’s achievements and prospects during a meeting of parent Novartis’ management.
Rather than hitting the acquisition trial, Biogen has taken the licensing route to expand its psychiatric and neurological disorders pipeline.